Chargement en cours...
Is Left Ventricular Hypertrophy a Modifiable Risk Factor in ESRD
PURPOSE OF REVIEW: Left ventricular hypertrophy (LVH) is common in ESRD and has been advocated as a therapeutic target. We review considerations for targeting LVH as a modifiable risk factor in ESRD. RECENT FINDINGS: Pathologic myocardial changes underlying LVH provide an ideal substrate for the spr...
Enregistré dans:
| Publié dans: | Curr Opin Nephrol Hypertens |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4266593/ https://ncbi.nlm.nih.gov/pubmed/25295959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0000000000000067 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|